View source for 6qit


==Crystal structure of CAG repeats with synthetic CMBL3b compound==
<StructureSection load='6qit' size='340' side='right'caption='[[6qit]], [[Resolution|resolution]] 1.50&Aring;' scene=''>
== Structural highlights ==
<table><tr><td colspan='2'>[[6qit]] is a 4 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6QIT OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6QIT FirstGlance]. <br>
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=J48:CMBL3a'>J48</scene></td></tr>
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[6qiq|6qiq]], [[6qis|6qis]], [[6qir|6qir]]</td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6qit FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6qit OCA], [http://pdbe.org/6qit PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6qit RCSB], [http://www.ebi.ac.uk/pdbsum/6qit PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6qit ProSAT]</span></td></tr>
</table>
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
The trinucleotide repeat expansion disorders (TREDs) constitute of a group of &gt;40 hereditary neurodegenerative human diseases associated with abnormal expansion of repeated sequences, such as CAG repeats. The pathogenic factor is a transcribed RNA or protein whose function in the cell is compromised. The disorders are progressive and incurable. Consequently, many ongoing studies are oriented at developing therapies. We have analyzed crystal structures of RNA containing CAG repeats in complex with synthetic cyclic mismatch-binding ligands (CMBLs). The models show well-defined interactions between the molecules in which the CMBLs mimic nucleobases as they form pseudo-canonical base pairs with adenosine residues and engage in extensive stacking interactions with neighboring nucleotides. The binding of ligands is associated with major structural changes of the CAG repeats, which is consistent with results of biochemical studies. The results constitute an early characterization of the first lead compounds in the search for therapy against TREDs. The crystallographic data indicate how the compounds could be further refined in future biomedical studies.

Structural insights into synthetic ligands targeting A-A pairs in disease-related CAG RNA repeats.,Mukherjee S, Blaszczyk L, Rypniewski W, Falschlunger C, Micura R, Murata A, Dohno C, Nakatani K, Kiliszek A Nucleic Acids Res. 2019 Sep 30. pii: 5576126. doi: 10.1093/nar/gkz832. PMID:31566242<ref>PMID:31566242</ref>

From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
</div>
<div class="pdbe-citations 6qit" style="background-color:#fffaf0;"></div>
== References ==
<references/>
__TOC__
</StructureSection>
[[Category: Large Structures]]
[[Category: Blaszczyk, L]]
[[Category: Kiliszek, A]]
[[Category: Nakatani, K]]
[[Category: Rypniewski, W]]
[[Category: Cag repeat]]
[[Category: Cmbl]]
[[Category: Rna]]
[[Category: Rna complex with ligand]]